HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaoli Wei Selected Research

Non-alcoholic Fatty Liver Disease

3/2023G protein-coupled receptor 35 attenuates nonalcoholic steatohepatitis by reprogramming cholesterol homeostasis in hepatocytes.
7/2022Loss of TRIM67 Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease.
1/2018Dietary copper-fructose interactions alter gut microbial activity in male rats.
9/2015Effects of Dietary Different Doses of Copper and High Fructose Feeding on Rat Fecal Metabolome.
7/2012Metabolomic analysis of the effects of polychlorinated biphenyls in nonalcoholic fatty liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaoli Wei Research Topics

Disease

50Neoplasms (Cancer)
03/2024 - 02/2009
9Stomach Neoplasms (Stomach Cancer)
01/2022 - 11/2014
9Glioma (Gliomas)
01/2018 - 11/2015
8Glioblastoma (Glioblastoma Multiforme)
10/2017 - 04/2012
7Infections
11/2022 - 01/2018
6Inflammation (Inflammations)
01/2023 - 02/2014
5Fatty Liver
03/2023 - 01/2013
5Non-alcoholic Fatty Liver Disease
03/2023 - 07/2012
5Brain Neoplasms (Brain Tumor)
01/2018 - 06/2012
4Neoplasm Metastasis (Metastasis)
03/2024 - 10/2016
4Bacterial Infections (Bacterial Infection)
11/2022 - 09/2017
4Lung Neoplasms (Lung Cancer)
03/2021 - 06/2009
3Carcinoma (Carcinomatosis)
03/2024 - 05/2014
3Melanoma (Melanoma, Malignant)
02/2023 - 05/2014
3HIV Infections (HIV Infection)
12/2022 - 01/2019
3Obesity
07/2022 - 07/2012
3Pain (Aches)
09/2020 - 08/2014
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2019 - 01/2012
2Colorectal Neoplasms (Colorectal Cancer)
09/2023 - 10/2016
2Stroke (Strokes)
06/2023 - 01/2023
2Breast Neoplasms (Breast Cancer)
01/2023 - 05/2014
2Pneumonia (Pneumonitis)
11/2022 - 01/2022
2Carcinogenesis
07/2022 - 02/2009
2Asthenozoospermia
01/2022 - 12/2019
2Body Weight (Weight, Body)
01/2022 - 12/2007
2Hepatocellular Carcinoma (Hepatoma)
01/2020 - 11/2017
2Endotoxemia
04/2016 - 02/2015
2Kidney Neoplasms (Kidney Cancer)
01/2011 - 04/2010
1Disease Progression
11/2023
1Nasopharyngeal Carcinoma
11/2023
1Acute Liver Failure (Fulminant Hepatic Failure)
03/2023

Drug/Important Bio-Agent (IBA)

17Proteins (Proteins, Gene)FDA Link
01/2024 - 06/2009
13Liposomes (Liposome)IBA
11/2022 - 01/2012
13Peptides (Polypeptides)IBA
07/2020 - 01/2012
11LigandsIBA
01/2022 - 06/2012
9Doxorubicin (Adriamycin)FDA LinkGeneric
01/2018 - 10/2013
6Antineoplastic Agents (Antineoplastics)IBA
05/2013 - 06/2009
5Biomarkers (Surrogate Marker)IBA
11/2023 - 06/2009
5FructoseIBA
09/2023 - 09/2015
4Phosphotransferases (Kinase)IBA
09/2023 - 12/2010
4LipidsIBA
11/2022 - 01/2013
4EnzymesIBA
01/2022 - 07/2012
4Contrast MediaIBA
07/2019 - 01/2016
4IntegrinsIBA
01/2018 - 06/2012
4Neuropilin-1IBA
12/2016 - 10/2013
4NSC-741909IBA
01/2011 - 06/2009
3AntioxidantsIBA
03/2023 - 07/2012
3VaccinesIBA
12/2022 - 10/2014
3Dyneins (Dynein)IBA
01/2022 - 12/2019
3Cisplatin (Platino)FDA LinkGeneric
08/2019 - 08/2017
3GadoliniumIBA
07/2019 - 01/2016
3MicellesIBA
01/2018 - 06/2012
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
12/2016 - 06/2016
2Immune Checkpoint InhibitorsIBA
11/2023 - 02/2016
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2023 - 10/2019
2Cysteine (L-Cysteine)FDA Link
01/2023 - 01/2021
2Messenger RNA (mRNA)IBA
01/2023 - 08/2014
2Peptide Hydrolases (Proteases)FDA Link
01/2023 - 01/2021
2Anti-Bacterial Agents (Antibiotics)IBA
11/2022 - 01/2022
2CytokinesIBA
07/2022 - 01/2022
2Therapeutic UsesIBA
02/2022 - 10/2013
2Ethanol (Ethyl Alcohol)IBA
01/2022 - 04/2016
2NanovaccinesIBA
01/2022 - 10/2019
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
03/2021 - 12/2010
2Long Noncoding RNAIBA
01/2021 - 11/2017
2MicroRNAs (MicroRNA)IBA
01/2021 - 08/2019
2CopperIBA
01/2018 - 09/2015
2polyethylene glycol- distearoylphosphatidylethanolamineIBA
10/2017 - 10/2014
2cyclic arginine-glycine-aspartic acid peptideIBA
09/2017 - 06/2012
2salinomycinIBA
08/2017 - 08/2017
2Glutamic Acid (Glutamate)FDA Link
05/2017 - 08/2013
2IsoenzymesIBA
04/2017 - 02/2017
2Pyruvate KinaseIBA
04/2017 - 02/2017
2Tumor Biomarkers (Tumor Markers)IBA
04/2017 - 02/2017
2Cholinergic ReceptorsIBA
11/2016 - 11/2015
2NicotineFDA Link
11/2016 - 11/2015
2PolymersIBA
11/2016 - 01/2016
2Glucose (Dextrose)FDA LinkGeneric
06/2016 - 08/2013
2Triglycerides (Triacylglycerol)IBA
04/2016 - 01/2013
2PolyethyleneimineIBA
08/2015 - 06/2012
2poly(ethylene glycol)-co-poly(ethyleneimine)IBA
08/2015 - 06/2012
2Fatty Acids (Saturated Fatty Acids)IBA
02/2015 - 01/2013
2oncrasin-1IBA
04/2011 - 01/2011
2RNA Polymerase II (RNA Polymerase B)IBA
04/2011 - 01/2011
2indoleIBA
12/2010 - 02/2009
1Interleukin-8 (Interleukin 8)IBA
03/2024
1CyclinsIBA
03/2024
1Transcription Factor TFIIB (TFIIB)IBA
03/2024
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2023
1B7-H1 AntigenIBA
11/2023
1Acetaminophen (Paracetamol)FDA LinkGeneric
03/2023
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2023
1Kynurenic Acid (Kynurenate)IBA
03/2023

Therapy/Procedure

22Therapeutics
11/2023 - 01/2012
5Immunotherapy
03/2024 - 02/2016
4Drug Therapy (Chemotherapy)
08/2019 - 06/2014
3Aftercare (After-Treatment)
01/2023 - 06/2009
2Mirror Movement Therapy
06/2023 - 01/2023
2Intravenous Injections
01/2022 - 09/2020
2Intravenous Administration
04/2016 - 04/2012